← FDA Drug Approvals (Drugs@FDA)
METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2021-04-16
Drug application
- FDA Application #
ANDA213334- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- METFORMIN HYDROCHLORIDE
- Generic name
- METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS
- Active ingredients
- METFORMIN HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- ScieGen Pharmaceuticals, Inc.
- First approval
- 2021-04-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown